Unexplained weight loss, defined as a loss of 5% or more of body weight within a six to twelve-month period, can be a harbinger of serious underlying disease. This article aims to provide a comprehensive approach towards diagnosing the underlying cause.
The first step in evaluating unexplained weight loss is a detailed history and physical examination. This includes an assessment of dietary intake, physical activity levels, psychiatric status, and a comprehensive review of systems. The physical examination should focus on signs of underlying systemic disease.
Initial diagnostic tests should include a complete blood count, metabolic panel, thyroid function tests, urine analysis, and stool tests if indicated. Imaging studies such as chest X-ray, abdominal ultrasound or CT scan may be warranted based on the patient's presenting symptoms and signs. Endoscopy and colonoscopy may be considered in patients above 50 years of age or in those with alarming symptoms.
Special considerations should be given to elderly patients, as weight loss in this population can be associated with malignancy, depression, or social isolation. In younger patients, eating disorders and malabsorption syndromes should be considered.
Management should be targeted towards the underlying cause. If no cause is identified after initial evaluation and testing, close follow-up is recommended. A stepwise approach to further testing should be considered, to avoid unnecessary investigations and to minimize patient distress.
In conclusion, unexplained weight loss is a complex clinical problem that requires a systematic approach. A thorough history and physical examination, coupled with appropriate diagnostic testing, can help identify the underlying cause and guide management.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation